Industry
Biotechnology
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
January 10, 2024 | 9:31 pm
Portfolio Pulse from Benzinga Insights
December 15, 2023 | 3:01 pm
Portfolio Pulse from Benzinga Newsdesk
December 15, 2023 | 2:43 pm
Portfolio Pulse from Benzinga Newsdesk
November 20, 2023 | 1:31 pm
Portfolio Pulse from Benzinga Newsdesk
November 20, 2023 | 11:13 am
Portfolio Pulse from Benzinga Insights
November 17, 2023 | 6:00 pm
Portfolio Pulse from Benzinga Newsdesk
November 17, 2023 | 5:15 pm
Portfolio Pulse from Benzinga Newsdesk
November 16, 2023 | 9:37 pm
Portfolio Pulse from Benzinga Newsdesk
October 30, 2023 | 12:36 pm
Portfolio Pulse from Benzinga Insights
October 25, 2023 | 9:31 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.